From: Month Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
To: Month Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Comments Regarding Proposed DCF Amendments to Glossary Regulations in 110 CMR 2.00
/Advocacy/State-Advocacy/State-Regulatory-Comments/Comments-Regarding-Proposed-DCF-Amendments-to-Glossary-Regulations-in-110-CMR-2-00/
Sign-on Letter to HHS Secretary Regarding HIPAA-related Reporting Requirements Involving the Change Healthcare Cyber Incident
/Advocacy/Federal-Advocacy/Federal-Advocacy-Letters/Sign-on-Letter-to-HHS-Secretary-Regarding-HIPAA-related-Reporting-Requirements-Involving-the-Change-Healthcare-Cyber-Incident/
Mind the Gap Coalition Testimony in Support of an Act relative to Insurance Coverage for Doula Services
/Advocacy/State-Advocacy/State-Testimony/Mind-the-Gap-Coalition-Testimony-in-Support-of-an-Act-relative-to-Insurance-Coverage-for-Doula-Services/
Comments on the 2024 Health Care Cost Growth Benchmark Before the Health Policy Commission
/Advocacy/State-Advocacy/State-Regulatory-Comments/Comments-on-the-2024-Health-Care-Cost-Growth-Benchmark-Before-the-Health-Policy-Commission/
Comments on Proposed Rule, Medicaid Program; Preserving Medicaid Funding for Vulnerable Populations - Closing a Health Care-Related Tax Loophole Proposed Rule
/Advocacy/Federal-Advocacy/Federal-Regulatory-Comments/Comments-on-Proposed-Rule,-Medicaid-Program;-Preserving-Medicaid-Funding-for-Vulnerable-Populations---Closing-a-Health-Care-Related-Tax-Loophole-Proposed-Rule/
Letter regarding Market Oversight legislation to the House Speaker and Senate President (PDF)
/Advocacy/State-Advocacy/State-Advocacy-Letters/Letter-regarding-Market-Oversight-legislation-to-the-House-Speaker-and-Senate-President-(PDF)/
Comments to DEA Regarding Buprenorphine Telehealth Regulation
/Advocacy/Federal-Advocacy/Federal-Regulatory-Comments/Comments-to-DEA-Regarding-Buprenorphine-Telehealth-Regulation/
Letter to Chair of Senate Ways and Means Committee Regarding FY 26 Budget Amendments
/Advocacy/State-Advocacy/State-Advocacy-Letters/Letter-to-Chair-of-Senate-Ways-and-Means-Committee-Regarding-FY-26-Budget-Amendments/
Testimony in Opposition to an Act Relative to The Regulation and Taxation of Natural Psychedelic Substances
/Advocacy/State-Advocacy/State-Testimony/Testimony-in-Opposition-to-an-Act-Relative-to-The-Regulation-and-Taxation-of-Natural-Psychedelic-Substances/
Testimony in Support of An Act to Improve Outdoor Lighting, Conserve Energy and Increase Dark-Sky Visibility (PDF)
/Advocacy/State-Advocacy/State-Testimony/Testimony-in-Support-of-An-Act-to-Improve-Outdoor-Lighting,-Conserve-Energy-and-Increase-Dark-Sky-Visibility-(PDF)/
Copyright © 2026. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411
(781) 893-4610 | General Support: (617) 841-2925 or support@mms.org